. Author manuscript; available in PMC: 2023 Jan 1.

Published in final edited form as: J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221074585. doi: 10.1177/10742484221074585

Table 4:

Multivariable linear regression for the effect of elevated ALT on SPECT-MPI perfusion defect results (95% confidence intervals) adjusted for: gender, age, diabetes mellitus, congestive heart failure, hypertension, family history of premature coronary heart disease, current smoker, obesity and dyslipidemia.

	B (CI) for elevated ALT	p-value
Stress perfusion defect (% myocardium)	0.1(−0.07–0.28)	0.26
Fixed perfusion defect (% myocardium)	0.09(−0.07–0.26)	0.25
Reversible perfusion defect (% myocardium)	0.004(−0.07–0.08)	0.91